CSIMarket
 


Gilead Sciences Inc   (GILD)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

GILD's Operating Income Growth by Quarter and Year

Gilead Sciences Inc 's Operating Income results by quarter and year




GILD Operating Income (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - 2,651.00 1,093.00 1,144.00
III Quarter September - 2,001.00 -1,473.00 2,623.00
II Quarter June - -2,983.00 2,430.00 2,280.00
I Quarter March 2,890.00 2,402.00 2,237.00 2,153.00
FY   2,890.00 4,071.00 4,287.00 8,200.00



GILD Operating Income first quarter 2021 Y/Y Growth Comment
Gilead Sciences Inc reported Operating Income improvement of 20.32% year on year in the first quarter, to $ 2,890.00 millions, this is lower than Gilead Sciences Inc 's recent average Operating Income rise of 42.93%.

Looking into first quarter results within Biotechnology & Drugs industry 7 other companies have achieved higher Operating Income growth. While Gilead Sciences Inc ' s Operating Income rise of 20.32% ranks overall at the positon no. 679 in the first quarter.

Explain Operating Income growth


GILD Operating Income ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - 142.54 % -4.46 % -50.07 %
III Quarter September - - - -31.19 %
II Quarter June - - 6.58 % -46.4 %
I Quarter March 20.32 % 7.38 % 3.9 % -42.85 %
FY   - -5.04 % -47.72 % -41.94 %

Financial Statements
Gilead Sciences Inc 's first quarter 2021 Operating Income $ 2,890.00 millions GILD's Income Statement
Gilead Sciences Inc 's first quarter 2020 Operating Income $ 2,402.00 millions Quarterly GILD's Income Statement
New: More GILD's historic Operating Income Growth >>


GILD Operating Income (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - 32.48 % - -56.39 %
III Quarter September - - - 15.04 %
II Quarter June - - 8.63 % 5.9 %
I Quarter March 9.02 % 119.76 % 95.54 % -6.02 %
FY (Year on Year)   - -5.04 % -47.72 % -41.94 %




Operating Income first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #8
Healthcare Sector #43
Overall #679

Operating Income Y/Y Growth Statistics
High Average Low
2136.92 % 42.93 % -48.57 %
(Dec. 31, 2007)   (Sep 30 2019)
Operating Income first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #8
Healthcare Sector #43
Overall #679
Operating Income Y/Y Growth Statistics
High Average Low
2136.92 % 42.93 % -48.57 %
(Dec. 31, 2007)   (Sep 30 2019)

Operating Income by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Gilead Sciences Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
154.18 % 10.09 % -84.25 %
(March 31, 2014)  


GILD's I. Quarter Q/Q Operating Income Comment
Gilead Sciences Inc achieved in the I. Quarter 2021 below company average Operating Income increase of 9.02% quarter on quarter, to $ 2,890.00 millions.

Within Biotechnology & Drugs industry 5 other companies have achieved higher Operating Income quarter on quarter growth. While Gilead Sciences Inc 's Operating Income growth quarter on quarter, overall rank is 633.


Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #6
Healthcare Sector #38
Overall #633
Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #6
Healthcare Sector #38
Overall #633
Operating Income Q/Q Growth Statistics
High Average Low
154.18 % 10.09 % -84.25 %
(March 31, 2014)  


GILD's I. Quarter Q/Q Operating Income Comment
Gilead Sciences Inc achieved in the I. Quarter 2021 below company average Operating Income increase of 9.02% quarter on quarter, to $ 2,890.00 millions.

Within Biotechnology & Drugs industry 5 other companies have achieved higher Operating Income quarter on quarter growth. While Gilead Sciences Inc 's Operating Income growth quarter on quarter, overall rank is 633.


Gilead Sciences Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
Cumulative Operating Income 12 Months Ending $ 4,559.00 $ 4,071.00 $ 2,513.00 $ -961.00 $ 4,452.00
Y / Y Operating Income Growth (TTM) 2.4 % -5.04 % -42.07 % - -46.26 %
Year on Year Operating Income Growth Overall Ranking # 843 # 735 # 933 # 0 # 1027
Seqeuential Operating Income Change (TTM) 11.99 % 62 % - - 3.85 %
Seq. Operating Income Growth (TTM) Overall Ranking # 679 # 185 # 182 # 0 # 591




Cumulative Operating Income growth Comment
Although Gilead Sciences Inc 's Annual Operating Income growth year on year were below company's average 63.07% , Operating Income announced in the Mar 31 2021 period, show improvement in Operating Income trend, to cumulative trailing twelve month growth of 2.4% year on year, from -5.04% in Dec 31 2020.

In the Healthcare sector 65 other companies have achieved higher trailing twelve month Operating Income growth. While Operating Income growth total ranking has deteriorated compare to previous quarter from 735 to 843.

Operating Income TTM Q/Q Growth Statistics
High Average Low
2136.92 %
42.93 %
-48.57 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry # 8
Healthcare Sector # 66
Overall # 843

Operating Income TTM Y/Y Growth Statistics
High Average Low
2464.91 %
63.07 %
-91.63 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 8
Sector # 43
S&P 500 # 679
Cumulative Operating Income growth Comment
Although Gilead Sciences Inc 's Annual Operating Income growth year on year were below company's average 63.07% , Operating Income announced in the Mar 31 2021 period, show improvement in Operating Income trend, to cumulative trailing twelve month growth of 2.4% year on year, from -5.04% in Dec 31 2020.

In the Healthcare sector 65 other companies have achieved higher trailing twelve month Operating Income growth. While Operating Income growth total ranking has deteriorated compare to previous quarter from 735 to 843.

Operating Income TTM Q/Q Growth Statistics
High Average Low
2136.92 %
42.93 %
-48.57 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry # 8
Healthcare Sector # 66
Overall # 843

Operating Income TTM Y/Y Growth Statistics
High Average Low
2464.91 %
63.07 %
-91.63 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 8
Sector # 43
S&P 500 # 679




Other Operating Income Growth
Biotechnology & Drugs Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
GILD's Operating Income Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for GILD's Competitors
Operating Income Growth for Gilead Sciences Inc 's Suppliers
Operating Income Growth for GILD's Customers

You may also want to know
GILD's Annual Growth Rates GILD's Profitability Ratios GILD's Asset Turnover Ratio GILD's Dividend Growth
GILD's Roe GILD's Valuation Ratios GILD's Financial Strength Ratios GILD's Dividend Payout Ratio
GILD's Roa GILD's Inventory Turnover Ratio GILD's Growth Rates GILD's Dividend Comparisons



Companies with similar Operating Income increase for the quarter ending Mar 31 2021 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Mar 31 2021
Medpace Holdings inc 34.07%$ 34.067 millions
Henry Schein Inc 32.25%$ 32.245 millions
Charles River Laboratories International inc 31.21%$ 31.207 millions
Hill rom Holdings Inc 30.93%$ 30.928 millions
Universal Health Services Inc24.92%$ 24.916 millions
Syneos Health Inc 24.60%$ 24.604 millions
Ligand Pharmaceuticals Incorporated24.47%$ 24.472 millions
Biodelivery Sciences International Inc 24.34%$ 24.340 millions
Vertex Pharmaceuticals Inc23.27%$ 23.271 millions
Gilead Sciences Inc 20.32%$ 20.316 millions
Becton Dickinson And Company17.30%$ 17.297 millions
Hca Healthcare Inc 14.89%$ 14.895 millions
Addus Homecare Corporation14.15%$ 14.154 millions
Abbvie Inc 13.88%$ 13.877 millions
Pacira Biosciences inc 13.71%$ 13.707 millions
Magellan Health inc 13.44%$ 13.441 millions
Integra Lifesciences Holdings Corp13.32%$ 13.323 millions
Ensign Group Inc12.12%$ 12.125 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

AVLR's Profile

Stock Price

AVLR's Financials

Business Description

Fundamentals

Charts & Quotes

AVLR's News

Suppliers

AVLR's Competitors

Customers & Markets

Economic Indicators

AVLR's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071